Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Health Information Services

Veeva Systems Inc. provides cloud-based business services. The Company offers enterprise applications, multichannel platform, customer relationship, and content management solutions. Veeva Systems serves customers in the United States.



Growth: Good revenue growth rate 16.0%, there is acceleration compared to average historical growth rates 14.1%. The revenue growth dynamics is stable

Profitability: LTM EBITDA margin is positive, +28.6%. On average the margin is improving unsteadily. Gross margin is high, +75.4%. In the last quarter the company beat the estimated EPS, +15.2%. The company was ahead of estimated EPS in 100% of quarters (showing a gain of +$0.08 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield 5.2% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 17.4% higher than minimum and 40.3% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 3.6x by EV / Sales multiple , the company can be 52.2% overvalued

Insiders: For the last 3 months insiders sold company shares on $0.4 mln (-0.002% of cap.)

Key Financials (Download financials)

Ticker: VEEV
Share price, USD:  (-3.0%)182.94
year average price 249.50  


year start price 283.57 2025-06-04

max close price 306.22 2025-10-07

min close price 155.76 2026-05-13

current price 182.94 2026-06-03
Common stocks: 164 049 000

Dividend Yield:  0.0%
FCF Yield LTM: 5.2%
EV / LTM EBITDA: 26.6x
EV / EBITDA annualized: 24.7x
Last revenue growth (y/y):  +16.0%
Last growth of EBITDA (y/y):  +32.1%
Historical revenue growth:  +14.1%
Historical growth of EBITDA:  +27.8%
EV / Sales: 7.6x
Margin (EBITDA LTM / Revenue): 28.6%
Fundamental value created in LTM:
Market Cap ($m): 30 011
Net Debt ($m): -6 548
EV (Enterprise Value): 23 463
Price to Book: 4.4x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2026-01-23zacks.com

Veeva Systems (VEEV) Stock Falls Amid Market Uptick: What Investors Need to Know

2026-01-22zacks.com

Veeva Systems (VEEV) Rises Higher Than Market: Key Facts

2026-01-13seekingalpha.com

Veeva Systems Inc. (VEEV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

2026-01-13zacks.com

Wall Street Analysts Think Veeva (VEEV) Is a Good Investment: Is It?

2025-12-29zacks.com

Reasons to Hold Veeva Systems Stock in Your Portfolio for Now

2025-12-19zacks.com

Veeva Systems (VEEV) is a Top-Ranked Growth Stock: Should You Buy?

2025-12-03prnewswire.com

Veeva AI Agents Now Available to Increase Productivity and Customer Centricity

2025-11-30seekingalpha.com

Veeva Systems: Unjustified Sell-Off, Justified Opportunity

2025-11-24zacks.com

Veeva (VEEV) International Revenue Performance Explored

2025-11-22seekingalpha.com

Veeva Systems: Sell-Off After Q3 Results Was Justified
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2025 q1 2024 q4 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-10-31 2025-07-31 2025-04-30 2025-01-31 2024-07-31 2024-04-30 2024-01-31 2023-10-31 2023-07-31 2023-04-30 2023-01-31 2022-10-31 2022-01-31 2021-01-31
symbol VEEV VEEV VEEV VEEV VEEV VEEV VEEV VEEV VEEV VEEV VEEV VEEV VEEV VEEV
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-21 2025-08-29 2025-06-02 2024-09-04 2024-06-04 2023-12-07 2023-09-01 2023-06-02 2022-12-07
acceptedDate 2025-11-21 16:07:12 2025-08-29 16:08:03 2025-06-02 16:05:29 2025-03-24 16:05:48 2024-09-04 16:06:55 2024-06-03 18:24:12 2024-03-25 16:06:01 2023-12-07 16:04:36 2023-09-01 16:01:51 2023-06-02 16:06:10 2023-03-30 16:06:48 2022-12-07 16:08:28 2022-03-30 17:08:05 2021-03-30 16:53:51
calendarYear 2026 2026 2026 2025 2025 2024 2024 2024 2023
period Q3 Q2 Q1 FY Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
revenue 811M 789M 759M 2 747M 676M 650M 2 364M 617M 590M 526M 2 155M 552M 1 851M 1 465M
costOfRevenue 199M 195M 174M 700M 170M 174M 677M 168M 169M 167M 609M 154M 504M 409M
grossProfit 612M 594M 585M 2 047M 506M 476M 1 686M 449M 421M 360M 1 546M 398M 1 347M 1 056M
grossProfitRatio 0.754 0.753 0.771 0.748 0.733 0.728 0.714 0.683 0.721
researchAndDevelopmentExpenses 192M 193M 184M 693M 176M 163M 629M 161M 157M 147M 520M 130M 382M 294M
generalAndAdministrativeExpenses 68M 96M 69M 266M 61M 61M 247M 62M 86M 83M 218M 53M 172M 149M
sellingAndMarketingExpenses 111M 109M 99M 397M 102M 97M 381M 97M 74M 68M 349M 94M 288M 235M
sellingGeneralAndAdministrativeExpenses 179M 205M 167M 662M 163M 159M 628M 159M 160M 151M 566M 147M 460M 384M
otherExpenses 0 0 0 0 0 52M 0 42M 39M 30M 0 0 0 0
operatingExpenses 371M 398M 351M 1 356M 339M 321M 1 257M 320M 317M 298M 1 087M 277M 842M 678M
costAndExpenses 570M 593M 525M 2 055M 510M 495M 1 934M 488M 486M 465M 1 696M 431M 1 345M 1 087M
interestIncome 0 0 0 208M 0 0 134M 0 31M 0 46M 0 15M 16M
interestExpense 0 0 0 0 0 0 0 0 0 -30M 0 -12M 0 0
depreciationAndAmortization 20M 10M 10M 39M 11M 8M 33M 8M 8M 8M 29M 7M 27M 29M
ebitda 261M 206M 244M 731M 178M 164M 462M 137M 112M 69M 488M 129M 533M 407M
ebitdaratio 0.321 0.261 0.321 0.263 0.252 0.222 0.19 0.131 0.233
operatingIncome 241M 196M 234M 691M 166M 155M 429M 128M 104M 62M 459M 121M 505M 378M
operatingIncomeRatio 0.297 0.248 0.308 0.246 0.239 0.208 0.176 0.117 0.22
totalOtherIncomeExpensesNet 72M 69M 65M 228M 59M 52M 159M 42M 39M 30M 50M 12M 7M 16M
incomeBeforeTax 313M 265M 299M 919M 225M 207M 588M 171M 143M 92M 509M 134M 512M 394M
incomeBeforeTaxRatio 0.386 0.336 0.394 0.333 0.318 0.277 0.242 0.174 0.242
incomeTaxExpense 77M 65M 71M 205M 54M 45M 62M 36M 31M -40M 21M 25M 85M 14M
netIncome 236M 200M 228M 714M 171M 162M 526M 135M 112M 132M 488M 108M 427M 380M
netIncomeRatio 0.291 0.254 0.301 0.253 0.249 0.219 0.189 0.25 0.196
eps 1.44 1.23 1.4 4.41 1.06 1 3.27 0.84 0.7 0.82 3.14 0.7 2.79 2.52
epsdiluted 1.4 1.19 1.37 1.04 0.98 0.83 0.68 0.81 0.67
weightedAverageShsOut 164M 163M 163M 162M 162M 161M 161M 161M 163M 160M 155M 155M 153M 151M
weightedAverageShsOutDil 168M 167M 166M 165M 165M 164M 163M 164M 163M 163M 162M 162M 162M 161M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-03-24 2024-03-25 2023-03-30 2022-03-30 2021-03-30
fiscalYear 2025 2024 2023 2022 2021
netInterestIncome 208M 134M 46M 15M 16M
ebit 691M 429M 459M 505M 378M
nonOperatingIncomeExcludingInterest 0 0 0 0 0
netIncomeFromContinuingOperations 714M 526M 488M 427M 380M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome 714M 526M 488M 427M 380M
epsDiluted 4.32 3.22 3 2.63 2.36

Balance Sheet Statement

Property 2025 q3 2025 q2 2025 q1 2024 q4 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-10-31 2025-07-31 2025-04-30 2025-01-31 2024-07-31 2024-04-30 2024-01-31 2023-10-31 2023-07-31 2023-04-30 2023-01-31 2022-10-31 2022-01-31 2021-01-31
symbol VEEV VEEV VEEV VEEV VEEV VEEV VEEV VEEV VEEV VEEV VEEV VEEV VEEV VEEV
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-21 2025-08-29 2025-06-02 2024-09-04 2024-06-04 2023-12-07 2023-09-01 2023-06-02 2022-12-07
acceptedDate 2025-11-21 16:07:12 2025-08-29 16:08:03 2025-06-02 16:05:29 2025-03-24 16:05:48 2024-09-04 16:06:55 2024-06-03 18:24:12 2024-03-25 16:06:01 2023-12-07 16:04:36 2023-09-01 16:01:51 2023-06-02 16:06:10 2023-03-30 16:06:48 2022-12-07 16:08:28 2022-03-30 17:08:05 2021-03-30 16:53:51
calendarYear 2026 2026 2026 2025 2025 2024 2024 2024 2023
period Q3 Q2 Q1 FY Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
cashAndCashEquivalents 1 660M 1 930M 1 965M 1 119M 1 166M 1 197M 703M 744M 743M 1 094M 886M 865M 1 138M 731M
shortTermInvestments 4 977M 4 473M 4 103M 4 031M 3 719M 3 568M 3 324M 3 199M 3 126M 2 521M 2 216M 2 157M 1 238M 933M
cashAndShortTermInvestments 6 637M 6 404M 6 068M 5 150M 4 885M 4 765M 4 028M 3 942M 3 869M 3 615M 3 103M 3 023M 2 376M 1 664M
netReceivables 372M 472M 541M 1 057M 404M 401M 889M 300M 417M 451M 785M 325M 694M 612M
inventory 0 0 0 0 0 0 0 1 1 0 0 0 0 0
otherCurrentAssets 103M 118M 98M 101M 79M 79M 87M 93M 76M 122M 81M 39M 0 0
totalCurrentAssets 7 112M 6 995M 6 708M 6 309M 5 368M 5 245M 5 003M 4 336M 4 362M 4 188M 3 969M 3 386M 3 107M 2 311M
propertyPlantEquipmentNet 140M 133M 122M 120M 100M 103M 104M 106M 108M 102M 105M 108M 104M 111M
goodwill 440M 440M 440M 440M 440M 440M 440M 440M 440M 440M 440M 440M 440M 436M
intangibleAssets 33M 36M 41M 44M 53M 58M 63M 68M 73M 78M 82M 87M 102M 115M
goodwillAndIntangibleAssets 473M 476M 480M 484M 493M 498M 503M 508M 513M 518M 522M 527M 542M 551M
longTermInvestments 0 0 0 0 0 3M 0 20M 22M 0 0 -711M 0 0
taxAssets 287M 310M 366M 344M 291M 266M 233M 218M 184M 156M 137M 99M 5M 14M
otherNonCurrentAssets 86M 86M 89M 83M 79M 73M 67M 38M 39M 59M 71M 773M 58M 60M
totalNonCurrentAssets 985M 1 005M 1 058M 1 031M 963M 943M 908M 890M 866M 835M 835M 796M 709M 735M
otherAssets 0 0 0 0 0 1 0 0 0 0 0 0 0 0
totalAssets 8 097M 7 999M 7 765M 7 340M 6 331M 6 188M 5 911M 5 226M 5 228M 5 023M 4 804M 4 183M 3 816M 3 046M
accountPayables 33M 34M 37M 30M 28M 32M 32M 36M 50M 44M 42M 41M 20M 23M
shortTermDebt 11M 11M 11M 0 20M 21M 0 10M 11M 11M 0 12M 0 0
taxPayables 6M 4M 91M 9M 12M 77M 19M 7M 24M 5M 5M 54M 8M 3M
deferredRevenue 822M 1 108M 1 246M 1 274M 956M 1 029M 1 050M 644M 837M 870M 869M 510M 732M 617M
otherCurrentLiabilities 73M 99M 71M 19M 53M 64M 20M 78M 105M 81M 17M 128M 16M 30M
totalCurrentLiabilities 945M 1 255M 1 457M 1 398M 1 070M 1 223M 1 179M 768M 1 002M 1 006M 1 007M 690M 841M 716M
longTermDebt 79M 75M 67M 0 44M 45M 0 48M 48M 47M 0 50M 0 0
deferredRevenueNonCurrent 0 0 0 0 0 -1 0 0 0 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 367 000 439 000 526 000 587 000 591 000 705 000 2M 1M 1M 1M 1M 2M 2M 2M
otherNonCurrentLiabilities 32M 31M 30M 43M 31M 29M 39M 29M 24M 25M 30M -489M 18M 11M
totalNonCurrentLiabilities 112M 106M 97M 109M 76M 75M 87M 78M 74M 74M 81M 74M 64M 64M
otherLiabilities 0 0 0 0 0 1 0 0 0 0 0 0 0 0
capitalLeaseObligations 79M 75M 77M 76M 54M 56M 56M 58M 59M 58M 61M 62M 55M 63M
totalLiabilities 1 057M 1 361M 1 554M 1 507M 1 146M 1 298M 1 266M 846M 1 076M 1 080M 1 088M 764M 905M 780M
preferredStock 0 0 0 0 0 0 0 0 0 0 0 0 0 0
commonStock 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000
retainedEarnings 4 119M 3 883M 3 683M 3 455M 3 073M 2 902M 2 740M 2 593M 2 458M 2 346M 2 215M 2 026M 1 727M 1 300M
accumulatedOtherComprehensiveIncomeLoss 10M -2M 9M -8M -6M -31M -11M -38M -34M -26M -31M -46M -12M 992 000
othertotalStockholdersEquity 2 911M 2 757M 2 519M 2 117M 2 018M 1 824M 1 729M 1 623M 1 438M
totalStockholdersEquity 7 041M 6 639M 6 211M 5 832M 5 185M 4 889M 4 645M 4 380M 4 153M 3 943M 3 716M 3 419M 2 912M 2 266M
totalEquity 7 041M 6 639M 6 211M 5 832M 5 185M 4 889M 4 645M 4 380M 4 153M 3 943M 3 716M 3 419M 2 912M 2 266M
totalLiabilitiesAndStockholdersEquity 8 097M 7 999M 7 765M 6 331M 6 188M 5 226M 5 228M 5 023M 4 183M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 8 097M 7 999M 7 765M 7 340M 6 331M 6 188M 5 911M 5 226M 5 228M 5 023M 4 804M 4 183M 3 816M 3 046M
totalInvestments 4 977M 4 473M 4 103M 4 031M 3 719M 3 571M 3 324M 3 199M 3 126M 2 521M 2 216M 2 157M 1 238M 933M
totalDebt 90M 85M 77M 76M 54M 56M 56M 58M 59M 58M 61M 62M 55M 63M
netDebt -1 570M -1 845M -1 888M -1 043M -1 112M -1 141M -648M -686M -684M -1 035M -825M -803M -1 083M -667M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-03-24 2024-03-25 2023-03-30 2022-03-30 2021-03-30
fiscalYear 2025 2024 2023 2022 2021
accountsReceivables 1 016M 852M 703M 631M 564M
otherReceivables 41M 36M 82M 63M 47M
prepaids 0 0 0 37M 36M
totalPayables 67M 71M 79M 54M 46M
otherPayables 37M 40M 37M 34M 23M
accruedExpenses 28M 29M 31M 28M 11M
capitalLeaseObligationsCurrent 10M 9M 11M 11M 12M
capitalLeaseObligationsNonCurrent 66M 46M 50M 44M 51M
treasuryStock 0 0 0 0 0
additionalPaidInCapital 2 386M 1 915M 1 533M 1 197M 966M
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2025 q3 2025 q2 2025 q1 2024 q4 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-10-31 2025-07-31 2025-04-30 2025-01-31 2024-07-31 2024-04-30 2024-01-31 2023-10-31 2023-07-31 2023-04-30 2023-01-31 2022-10-31 2022-01-31 2021-01-31
symbol VEEV VEEV VEEV VEEV VEEV VEEV VEEV VEEV VEEV VEEV VEEV VEEV VEEV VEEV
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-21 2025-08-29 2025-06-02 2024-09-04 2024-06-04 2023-12-07 2023-09-01 2023-06-02 2022-12-07
acceptedDate 2025-11-21 16:07:12 2025-08-29 16:08:03 2025-06-02 16:05:29 2025-03-24 16:05:48 2024-09-04 16:06:55 2024-06-03 18:24:12 2024-03-25 16:06:01 2023-12-07 16:04:36 2023-09-01 16:01:51 2023-06-02 16:06:10 2023-03-30 16:06:48 2022-12-07 16:08:28 2022-03-30 17:08:05 2021-03-30 16:53:51
calendarYear 2026 2026 2026 2025 2025 2024 2024 2024 2023
period Q3 Q2 Q1 FY Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
netIncome 236M 200M 228M 714M 171M 162M 526M 135M 112M 132M 488M 108M 427M 380M
depreciationAndAmortization 0 13M 13M 51M 11M 11M 37M 8M 8M 8M 38M 7M 37M 39M
deferredIncomeTax 18M 59M -27M -112M -33M -27M -105M -33M -25M -22M -128M -31M 11M -1M
stockBasedCompensation 0 -2M 0 0 108M 96M 0 101M 103M 91M 0 93M 0 0
changeInWorkingCapital -198M -153M 545M 8M -162M 523M 61M -128M 68M 293M 7M -43M 21M -76M
accountsReceivables 101M 68M 515M -169M 0 488M -104M 123M 34M 290M -91M 69M -83M -188M
inventory 0 0 0 0 0 0 0 -45M 67M 0 0 0 0 0
accountsPayables -171 000 -4M 8M -2M -4M 280 000 -10M -14M 6M 2M 21M 10M -3M 754 000
otherWorkingCapital -298M -217M 22M 179M -158M 31M 175M -193M -38M 706 000 77M -122M 107M 112M
otherNonCashItems 136M 120M 118M 430M -2M -371M 393M -591 000 -548 000 5M 375M 8M 268M 209M
netCashProvidedByOperatingActivities 193M 238M 877M 1 090M 93M 764M 911M 83M 265M 506M 780M 143M 764M 551M
investmentsInPropertyPlantAndEquipment -10M -6M -6M -21M -3M -8M -26M -6M -10M 0 -14M -17 000 -14M -9M
acquisitionsNet 0 0 0 0 0 0 0 6M 10M 0 0 0 -8M 0
purchasesOfInvestments -933M -786M -667M -2 582M -614M -778M -2 698M -542M -988M -612M -1 997M -711M -1 117M -979M
salesMaturitiesOfInvestments 448M 403M 621M 1 902M 504M 514M 1 648M 474M 379M 318M 1 003M 311M 793M 654M
otherInvestingActivites 0 0 0 0 -8M -6M -10M -3M -6M
netCashUsedForInvestingActivites -495M -389M -52M -114M -272M -73M -619M -297M -406M
debtRepayment 0 0 0 0 0 0 0 0 0
commonStockIssued 58M 142M 41M 6M 28M 14M 23M 0 5M
commonStockRepurchased 0 0 0 0 -18M -25M 0 -21M -20M 0 0 0 0 0
dividendsPaid 0 0 0 0 0 0 0 0 0
otherFinancingActivites -25M -26M -20M -11M 4M -21M 0 -1M -15M
netCashUsedProvidedByFinancingActivities 33M 116M 20M -11M 4M -7M 3M -1M -11M
effectOfForexChangesOnCash -494 000 599 000 766 000 -2M 5000 -1M -2M -1M 290 000 19 000 -5M -1M -5M 484 000
netChangeInCash -270M -35M 846M 414M -32M 494M -183M 1M -351M 207M -252M -275M 410M 252M
cashAtEndOfPeriod 1 660M 1 930M 1 967M 1 121M 1 168M 1 197M 707M 747M 746M 1 097M 890M 868M 1 141M 732M
cashAtBeginningOfPeriod 1 930M 1 965M 1 121M 707M 1 200M 703M 890M 746M 1 097M 890M 1 141M 1 143M 732M 480M
operatingCashFlow 193M 238M 877M 1 090M 93M 764M 911M 83M 265M 506M 780M 143M 764M 551M
capitalExpenditure -6M -6M -6M -21M -3M -8M -26M -6M -10M 0 -14M -17 000 -14M -9M
freeCashFlow 186M 232M 871M 1 070M 90M 755M 885M 77M 255M 506M 767M 143M 750M 543M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-03-24 2024-03-25 2023-03-30 2022-03-30 2021-03-30
fiscalYear 2025 2024 2023 2022 2021
otherInvestingActivities 0 0 0 0 0
netCashProvidedByInvestingActivities -700M -1 076M -1 008M -346M -334M
netDebtIssuance 0 0 0 -384 000 -1M
longTermNetDebtIssuance 0 0 0 -384 000 -1M
shortTermNetDebtIssuance 0 0 0 0 0
netStockIssuance 106M 63M 44M 52M 35M
netCommonStockIssuance 106M 63M 44M 52M 35M
commonStockIssuance 106M 63M 44M 52M 35M
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid 0 0 0 0 0
commonDividendsPaid 0 0 0 0 0
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities -79M -79M -63M -55M 0
netCashProvidedByFinancingActivities 26M -16M -19M -4M 34M
incomeTaxesPaid 322M 134M 168M 59M 18M
interestPaid 0 0 0 0 0

Earning call transcript

2026 q1
2025-05-28 ET (fiscal 2026 q1)
2025 q4
2025-03-05 ET (fiscal 2025 q4)
2025 q3
2024-12-05 ET (fiscal 2025 q3)
2025 q2
2024-08-28 ET (fiscal 2025 q2)
2025 q1
2024-05-30 ET (fiscal 2025 q1)
2024 q4
2024-02-29 ET (fiscal 2024 q4)
2024 q3
2023-12-06 ET (fiscal 2024 q3)
2024 q2
2023-08-30 ET (fiscal 2024 q2)
2024 q1
2023-05-31 ET (fiscal 2024 q1)
2023 q4
2023-03-02 ET (fiscal 2023 q4)
2023 q3
2022-12-01 ET (fiscal 2023 q3)
2023 q2
2022-08-31 ET (fiscal 2023 q2)
2023 q1
2022-06-01 ET (fiscal 2023 q1)
2022 q4
2023-03-01 ET (fiscal 2022 q4)
2022 q3
2021-12-01 ET (fiscal 2022 q3)
2022 q1
2021-05-27 ET (fiscal 2022 q1)

Press-releases

Show financial reports only

2026-05-28 11:03 ET
Veeva Quality Cloud Advances Manufacturing Operations for Kindeva
2026-05-27 11:03 ET
/C O R R E C T I O N -- Veeva Systems/
2026-05-27 11:03 ET
Veeva Announces Falcon, an Agentic Platform and Standard Agents to Deliver Agentic Labor in Drug Development
2026-05-27 11:03 ET
Merck KGaA, Darmstadt, Germany Selects Veeva Vault CRM Worldwide
2026-05-14 ET
Veeva Commercial Summit to Feature Biopharma's AI Successes and the Path to Agentic Commercial
2026-05-13 ET
Veeva to Release Fiscal 2027 First Quarter Results on June 3, 2026
2026-05-11 ET
Smith+Nephew Establishes Unified Quality Foundation Worldwide with Veeva Quality Cloud
2026-03-10 ET
Veeva Acquires Ostro, the Leading Brand Engagement Platform for Life Sciences
2026-03-10 ET
AOP Health Standardizes on Veeva Industry Cloud for Life Sciences Across All Business Areas
2026-03-04 ET
Veeva Announces Fourth Quarter and Fiscal Year 2026 Results
2026-03-03 ET
More Than 125 Customers Worldwide Live on Vault CRM as Veeva Accelerates the Industry's Agentic Transformation
2026-02-11 ET
Veeva to Release Fiscal 2026 Fourth Quarter and Full Year Results on March 4, 2026
2026-02-04 ET
13 of the Top 20 Biopharmas Standardize Globally on Veeva Link Key People
2026-01-29 ET
Veeva Announces eSource Application for Research Sites to Eliminate Paper and Streamline Clinical Trial Data Flow
2026-01-27 ET
Industry Research Finds Establishing a Foundation for AI is Top Priority for CPG Enterprises
2026-01-08 ET
Veeva to Present at the J.P. Morgan 2026 Healthcare Conference
2026-01-08 ET
Veeva Announces Environmental Monitoring Solution to Modernize Quality Control in Manufacturing
2026-01-07 ET
Novo Nordisk International Operations Commits to Veeva Vault CRM
2026-01-05 ET
Veeva Announces Share Repurchase Program
2025-12-04 ET
Veeva to Present at Upcoming Investor Conference
2025-12-03 ET
Veeva AI Agents Now Available to Increase Productivity and Customer Centricity
2025-11-24 ET
Veeva Announces Expanded Partnership with Roche
2025-11-20 ET
Veeva Announces Fiscal 2026 Third Quarter Results
2025-11-04 ET
Veeva Basics Adopted by More Than 100 Emerging Biotechs to Simplify and Standardize Operations
2025-10-30 ET
Veeva to Release Fiscal 2026 Third Quarter Results on November 20, 2025
2025-10-16 ET
OpenEvidence and Veeva Announce Open Vista Partnership
2025-10-14 ET
Veeva AI Agents to Be Released Across All Veeva Applications
2025-09-29 ET
Industry Research Finds Two-Thirds of Clinical Data Managers and CRAs Believe Current Inefficiencies Put Data Quality at Future Risk
2025-09-25 ET
Veeva to Host Virtual Investor Day on October 16, 2025
2025-09-22 ET
Bristol Myers Squibb Commits to Veeva Vault CRM
2025-09-10 ET
Gilead Sciences Commits to Veeva Vault CRM
2025-09-02 ET
Veeva to Present at Upcoming Investor Conference
2025-09-02 ET
More Than 450 Companies Drive Speed to Market with Veeva RIM
2025-08-28 ET
Veeva Announces Collaboration with Global Biotech to Further Accelerate Clinical Trial Innovation
2025-08-27 ET
Veeva Announces Fiscal 2026 Second Quarter Results
2025-08-21 ET
Leaders Come Together to Advance the Industry at Veeva Summit
2025-08-18 ET
IQVIA and Veeva Announce Long-term Clinical and Commercial Partnerships and Resolution of All Disputes
2025-08-18 ET
IQVIA and Veeva Announce Long-term Clinical and Commercial Partnerships and Resolution of All Disputes
2025-08-12 ET
Research Shows Medtechs Prioritizing Site Collaboration and Data Quality
2025-08-06 ET
Veeva to Release Fiscal 2026 Second Quarter Results on August 27, 2025
2025-07-30 ET
Survey Finds Medtechs Lack Confidence in Regulatory Data Quality
2025-07-23 ET
Veeva OpenData and Veeva Network Enable Coordinated Customer Engagement for Boehringer Ingelheim
2025-07-21 ET
Merck Commits to Veeva Vault CRM
2025-06-25 ET
Veeva and AWS Expand 10-Year Relationship
2025-06-11 ET
Medtech Industry Establishes Foundation for Clinical Trials with Veeva MedTech
2025-06-09 ET
New Study Finds 88% of Medtechs Prioritizing Postmarket Quality Modernization Within Next 3 Years
2025-06-04 ET
Veeva and Sarah Cannon Research Institute Form Strategic Collaboration to Advance Oncology Clinical Trials
2025-06-04 ET
Astellas Chooses Veeva Vault CRM as Global Standard
2025-05-30 ET
Veeva to Present at Upcoming Investor Conferences
2025-05-29 ET
Veeva Pulse Report Finds Content-Driven Engagement Lags Despite Proven Boost to Treatment Adoption
2025-05-28 ET
Veeva Announces Fiscal 2026 First Quarter Results
2025-05-20 ET
More Than 75 Emerging Biotechs Use Veeva Basics Across Clinical, Regulatory, and Quality
2025-05-07 ET
Veeva to Release Fiscal 2026 First Quarter Results on May 28, 2025
2025-05-06 ET
Life Sciences Leaders Advance Unified Engagement at Veeva Commercial Summit
2025-04-29 ET
Announcing Veeva AI
2025-04-01 ET
Veeva Announces Research Site Clinical Trial Management System
2025-03-19 ET
Indero Marks 40th Study Live with Veeva RTSM
2025-03-11 ET
Boehringer Ingelheim Partners with Veeva to Launch 'One Medicine Platform'
2025-03-05 ET
Veeva Announces Fourth Quarter and Fiscal Year 2025 Results
2025-03-04 ET
Veeva Commercial Pulse Improves Segmentation and Targeting with Brick-Level HCP Access Data for 21 Countries
2025-03-03 ET
Top Global Biopharmas Standardize on Veeva China CRM Suite
2025-02-27 ET
Veeva Direct Data API Now Included with Vault Platform to Enable AI Innovation
2025-02-12 ET
Veeva to Release Fiscal 2025 Fourth Quarter and Full Year Results on March 5, 2025
2025-01-29 ET
More Than 200 Companies Advance Trial Management with Veeva CTMS
2025-01-23 ET
Veeva and Zifo Partner to Accelerate Quality Control Modernization
2025-01-13 ET
Veeva to Present at Upcoming Investor Conference
2024-12-12 ET
A Growing Number of Biopharmas Leverage Veeva Compass Patient to Improve Commercialization
2024-12-10 ET
Veeva Delivers Vault CRM Suite with Vault CRM Campaign Manager
2024-12-09 ET
Veeva to Present at Upcoming Investor Conference
2024-12-05 21:05 ET
Veeva Announces Fiscal 2025 Third Quarter Results
2024-11-21 12:03 ET
Report Reveals 70% of Medtechs Use Manual Processes for Managing Content and Claims
2024-11-20 09:00 ET
Veeva Announces AI in Vault CRM
2024-11-19 12:03 ET
Veeva Announces New Digital Hazard Analysis and Critical Control Point (HACCP) Solution
2024-11-14 21:14 ET
Veeva to Release Fiscal 2025 Third Quarter Results on December 5, 2024
2024-11-14 15:03 ET
Boehringer Ingelheim Commits to Veeva Vault CRM
2024-11-14 12:03 ET
Veeva Pulse Data Shows New Science Calls for More Connected Engagement
2024-10-24 12:00 ET
Walgreens and Veeva Form Strategic Partnership
2024-10-02 11:03 ET
18 of the Top 20 Medtech Companies Partner with Veeva MedTech to Get Devices and Diagnostics to Patients Faster
2024-09-24 11:03 ET
Veeva Vault QMS Adds Field Actions and Recall Management for Medtech
2024-09-05 11:03 ET
Major Release of Veeva Site Connect Streamlines Clinical Trial Execution for Sites and Sponsors
2024-08-30 17:45 ET
Veeva to Present at Upcoming Investor Conference
2024-08-28 20:05 ET
Veeva Announces Fiscal 2025 Second Quarter Results
2024-08-27 11:03 ET
New Service Center in Veeva Vault CRM Suite Unifies Sales and Service
2024-08-22 11:03 ET
Veeva Vault LIMS Gains Momentum as Companies Unify Quality Assurance and Quality Control
2024-08-13 11:03 ET
Life Sciences Community Advances Toward Next Phase of Innovation at Veeva R&D and Quality Summit
2024-08-07 20:15 ET
Veeva to Release Fiscal 2025 Second Quarter Results on August 28, 2024
2024-07-25 13:03 ET
Targeted Pre-Launch Scientific Outreach Drives 40% Faster Treatment Adoption
2024-06-19 11:03 ET
Vita Global Sciences Partners with Veeva to Streamline Clinical Data Management
2024-06-06 11:03 ET
Tigermed Advances Clinical Data Management with Veeva Vault EDC
2024-06-03 20:15 ET
Veeva to Present at Upcoming Investor Conferences
2024-05-30 20:40 ET
Veeva Announces Fiscal 2025 First Quarter Results
2024-05-23 11:03 ET
New Veeva Pulse Findings Show Connected Engagement Creates an Advantage as HCP Access Drops
2024-05-22 11:03 ET
For the Second Year in a Row, Veeva MedTech Named Best Overall Medtech Software
2024-05-16 11:03 ET
Veeva Introduces Vault Basics for Biotechs
2024-05-08 20:15 ET
Veeva to Release Fiscal 2025 First Quarter Results on May 30, 2024
2024-04-23 11:03 ET
Top Biopharma Brands Reach Audiences 10x More Qualified with Veeva Crossix Prime Segments
2024-04-18 11:03 ET
Veeva Launches AI Partner Program
2024-04-17 11:03 ET
Veeva Announces Vault CRM Campaign Manager
2024-04-17 11:03 ET
Biopharma Leaders Come Together at Veeva Commercial Summit to Advance Customer-Centric Engagement
2024-04-01 13:03 ET
Veeva Vault CRM Now Available for All New Customers
2024-03-20 11:03 ET
Veeva Vault EDC Surpasses 1,000 Study Start Milestone
2024-03-04 21:05 ET
Veeva to Present at Upcoming Investor Conference
2024-02-29 21:05 ET
Veeva Announces Fourth Quarter and Fiscal Year 2024 Results
2024-02-14 12:03 ET
Boehringer Ingelheim Partners with Veeva to Advance its Clinical and Regulatory Operations in Animal Health
2024-02-12 12:03 ET
New Veeva Vault Submissions Publishing eLearning Application Speeds Employee Onboarding
2024-02-06 21:05 ET
Veeva to Release Fiscal 2024 Fourth Quarter and Full Year Results on February 29, 2024
2024-01-30 12:03 ET
Now Available: Veeva Compass Suite of Commercial Data Products
2024-01-18 12:03 ET
More Than 350 Companies Increase Efficiency and Compliance with Veeva Training Solutions
2024-01-17 12:03 ET
Veeva Completes Study Migrations to Veeva Vault EDC for Top Biopharma
2024-01-16 21:15 ET
Veeva to Present at Upcoming Investor Conference
2024-01-11 12:03 ET
Leading Pharma Adopts Veeva Vault Validation Management for Digital Validation Execution and Improved Efficiency
2024-01-08 18:14 ET
Veeva to Present at the 42nd Annual J.P. Morgan Healthcare Conference
2023-12-19 12:03 ET
Recipharm Harmonizes its Global Quality Operations with Veeva Vault Quality
2023-12-06 21:05 ET
Veeva Announces Fiscal 2024 Third Quarter Results
2023-11-27 12:03 ET
Top Biopharma Commits to Veeva Vault CRM for Global Customer Engagement
2023-11-27 12:03 ET
Bayer Commits to Veeva Vault CRM and Veeva OpenData Globally
2023-11-15 21:05 ET
Veeva to Release Fiscal 2024 Third Quarter Results on December 6, 2023
2023-11-15 12:03 ET
New Research Finds 87% of Medtechs Lack Consistent Methods to Share Product Information Across Global Regulatory Teams
2023-11-09 13:03 ET
Veeva Pulse Shows Doctors Opening Up Two-Way Communications Doubles Digital Engagement
2023-10-05 20:05 ET
Veeva to Host Virtual Investor Day on Nov. 9, 2023
2023-10-03 11:03 ET
LEO Pharma Connects Affiliates with Veeva Vault Safety to Transform Safety Operations
2023-09-13 13:00 ET
New Batch Release Application for Life Sciences Manufacturing to Speed Time-to-Market and Reduce Cost
2023-09-13 13:00 ET
Veeva Introduces Study Portal and VeevaID to Streamline Research Site Trial Execution
2023-09-01 16:44 ET
Veeva to Present at Upcoming Investor Conference
2023-08-31 11:03 ET
Veeva Clinical Database Crosses 200 Study Milestone, Cuts Time to Aggregate and Clean Study Data by 30-50%
2023-08-30 20:05 ET
Veeva Announces Fiscal 2024 Second Quarter Results
2023-08-28 14:03 ET
Veeva Announces First Customer Win and April 2024 Availability for Vault CRM - the Next Generation of CRM for Life Sciences
2023-08-22 11:03 ET
Veeva Vault LIMS to Support Civica Rx Quality Control
2023-08-17 11:03 ET
Veeva R&D and Quality Summit Brings Together Biopharma Leaders to Accelerate Innovation
2023-08-08 20:00 ET
Veeva to Release Fiscal 2024 Second Quarter Results on August 30, 2023
2023-07-26 11:03 ET
Veeva Pulse Uncovers Field Medical Engagement Drives 1.5x Increase in Treatment Adoption
2023-07-12 11:03 ET
Merck KGaA, Darmstadt, Germany Partners with Veeva to Transform Medical Information Operations Globally
2023-07-06 11:03 ET
St. Cloud State University and Veeva Partner to Deliver Real-World Clinical Technology Experience to Medtech Students
2023-06-06 08:00 ET
Veeva Business Consulting Expands with New R&D Services
2023-06-05 21:30 ET
Veeva to Present at Upcoming Investor Conferences
2023-06-05 11:03 ET
More Than 450 Companies Adopt Veeva Vault eTMF for Improved Trial Efficiency and Inspection Readiness
2023-05-31 20:05 ET
Veeva Announces Fiscal 2024 First Quarter Results
2023-05-30 11:03 ET
Lotus Clinical Research Expands Partnership with Veeva to Accelerate Clinical Trials
2023-05-24 11:03 ET
Minaris Regenerative Medicine Streamlining Contract Manufacturing with Veeva Vault Quality Suite Applications
2023-05-23 11:03 ET
UCB and Veeva Collaborate to Advance the Patient Experience in Clinical Trials
2023-05-18 11:03 ET
New Veeva Link MedTech Provides Real-Time Data to Optimize Scientific Engagement
2023-05-16 11:03 ET
Biopharmas Boost Marketing Effectiveness by 23% by Synchronizing Digital Media with Field Engagement
2023-05-10 11:03 ET
Veeva Partners with Sanofi to Transform its Quality System
2023-05-03 22:06 ET
Veeva to Release Fiscal 2024 First Quarter Results on May 31, 2023
2023-05-03 11:03 ET
Veeva Introduces Link Workflow, a No-Code Platform for Building Custom Workflow Applications
2023-05-02 13:00 ET
Veeva Expands Relationship with Accenture to Help Customers Transition to Vault CRM
2023-05-02 13:00 ET
Veeva Unveils Vault CRM, Next Generation of CRM for Life Sciences
2023-05-02 13:00 ET
Veeva Compass Modernizes Prescriber Data with New Approach Designed for Today's Complex Therapies
2023-04-20 11:03 ET
Life Sciences Brands Reach Clinically Relevant Audiences with New Veeva Crossix Prime Segments
2023-04-19 11:03 ET
Veeva MedTech Clinical Trials Report Signals Significant Opportunity to Improve Data Delivery and Quality
2023-04-18 11:03 ET
Veeva Commercial Summit Connects Nearly 1,500 Life Sciences Leaders Across Sales, Medical, and Marketing
2023-04-06 11:03 ET
Veeva Pulse Reveals Digital Content More Than Twice as Effective in Driving Promotional Response
2023-03-28 11:03 ET
More than 100 Biopharmas Increase Impactful Engagement with Veeva CRM Events Management
2023-03-01 21:05 ET
Veeva Announces Fourth Quarter and Fiscal Year 2023 Results
2023-02-28 12:03 ET
Industrywide Survey Reveals Centralizing Regulatory is Number One Priority for Medtech
2023-02-23 10:00 ET
Six of the Top 20 Pharma Select Veeva Vault EDC as Company Standard for New Trials
2023-02-16 12:03 ET
Modular Content Powers Omnichannel Engagement at Speed and Scale
2023-01-31 21:00 ET
Veeva to Release Fiscal 2023 Fourth Quarter and Full Year Results on March 1, 2023
2023-01-11 12:03 ET
Global CDMO Adare Pharma Solutions Harmonizing Quality with Veeva Vault Quality Suite
2023-01-10 12:03 ET
Veeva Statement in Support of Proposed FTC Rule to Ban Non-Competes
2023-01-09 22:43 ET
Veeva to Present at the 41st Annual J.P. Morgan Healthcare Conference
2022-12-14 12:03 ET
Veeva's Dan Crawford Elected Chair of CDISC Advisory Council
2022-12-01 21:05 ET
Veeva Announces Fiscal 2023 Third Quarter Results
2022-11-23 12:03 ET
Top Biopharmas Elevate Medical Engagement with Veeva Link Scientific Awareness
2022-11-15 12:03 ET
Veeva Pulse Shows Post-Pandemic HCP Access Nearing 80% in Key Specialties Driven by Digital Engagement
2022-11-09 21:00 ET
Veeva to Release Fiscal 2023 Third Quarter Results on December 1, 2022
2022-10-24 11:03 ET
Veeva Introduces Veeva Vault CRM for Medtech
2022-10-18 11:03 ET
Veeva CDB Application to Streamline Aggregation, Cleaning, and Transformation of Clinical Data
2022-10-18 11:03 ET
Veeva Introduces New ePRO Application for Faster Access to Patient Data
2022-10-17 11:03 ET
40 CROs Select Veeva Vault CTMS to Drive Clinical Trial Operations
2022-10-13 11:03 ET
New Veeva Link Applications Give Clinical Teams Real-Time Intelligence to Optimize Site Selection and Trial Design
2022-10-04 11:03 ET
Veeva Vault RIM Driving Greater Speed and Compliance for More Than 350 Life Sciences Organizations
2022-09-29 20:44 ET
Veeva to Host Virtual Financial Analyst and Investor Day on Nov. 3, 2022
2022-09-28 11:03 ET
Veeva Crossix Introduces New Products to Advance Omnichannel Marketing for Life Sciences Brands
2022-09-15 11:03 ET
Batavia Biosciences Optimizes Global Quality Assurance with Veeva Vault Quality Suite
2022-09-13 11:03 ET
More than 2,000 Biopharma Leaders Come Together at Veeva R&D and Quality Summit to Advance Drug Development

SEC forms

Show financial reports only

SEC form 10
2026-03-20 20:06 ET
Veeva Systems published news for 2025 q4
SEC form 8
2026-03-04 21:03 ET
Veeva Systems published news for 2025 q4
SEC form 8
2026-03-04 21:03 ET
Veeva Systems published news for 2025 q4
SEC form 8
2026-01-05 21:04 ET
Veeva Systems published news for 2025 q4
SEC form 8
2026-01-05 21:04 ET
Veeva Systems published news for 2025 q4
SEC form 10
2025-11-21 21:07 ET
Veeva Systems published news for 2025 q3
SEC form 8
2025-11-20 16:04 ET
Veeva Systems published news for 2025 q3
SEC form 8
2025-11-20 16:04 ET
Veeva Systems reported for 2025 q3
SEC form 8
2025-08-27 20:05 ET
Veeva Systems published news for 2025 q2
SEC form 8
2025-08-27 20:05 ET
Veeva Systems reported for 2025 q2
SEC form 8
2025-08-18 13:06 ET
Veeva Systems published news for 2025 q2
SEC form 8
2025-08-18 13:06 ET
Veeva Systems published news for 2025 q2
SEC form 8
2025-06-23 20:06 ET
Veeva Systems published news for 2025 q1
SEC form 10
2025-06-02 20:05 ET
Veeva Systems published news for 2025 q1
SEC form 8
2025-05-28 20:04 ET
Veeva Systems published news for 2025 q1
SEC form 8
2025-05-28 20:04 ET
Veeva Systems reported for 2025 q1
SEC form 10
2025-03-24 20:05 ET
Veeva Systems published news for 2024 q4
SEC form 10
2025-03-24 00:00 ET
Veeva Systems published news for 2024 q4
SEC form 8
2025-03-05 16:05 ET
Veeva Systems published news for 2024 q4
SEC form 8
2025-03-05 16:05 ET
Veeva Systems reported for 2024 q4
SEC form 10
2024-12-09 16:05 ET
Veeva Systems reported for 2024 q3
SEC form 10
2024-12-09 00:00 ET
Veeva Systems reported for 2024 q3
SEC form 8
2024-12-05 16:11 ET
Veeva Systems published news for 2024 q3
SEC form 8
2024-12-05 16:11 ET
Veeva Systems reported for 2024 q3
SEC form 8
2024-11-07 20:05 ET
Veeva Systems published news for 2024 q3
SEC form 8
2024-11-07 20:05 ET
Veeva Systems published news for 2024 q3
SEC form 10
2024-09-04 00:00 ET
Veeva Systems reported for 2024 q2
SEC form 8
2024-08-28 16:04 ET
Veeva Systems published news for 2024 q2
SEC form 8
2024-08-28 16:04 ET
Veeva Systems reported for 2024 q2
SEC form 10
2024-06-04 00:00 ET
Veeva Systems published news for 2024 q1
SEC form 8
2024-05-30 16:12 ET
Veeva Systems published news for 2024 q1
SEC form 8
2024-05-30 16:12 ET
Veeva Systems reported for 2024 q1
SEC form 10
2024-03-25 00:00 ET
Veeva Systems published news for 2023 q4
SEC form 8
2024-02-29 16:05 ET
Veeva Systems published news for 2023 q4
SEC form 8
2024-02-29 16:05 ET
Veeva Systems reported for 2023 q4
SEC form 10
2023-12-07 16:04 ET
Veeva Systems published news for 2023 q3
SEC form 10
2023-12-07 00:00 ET
Veeva Systems published news for 2023 q3
SEC form 8
2023-12-06 16:05 ET
Veeva Systems reported for 2023 q3
SEC form 8
2023-11-09 00:00 ET
Veeva Systems published news for 2023 q3
SEC form 10
2023-09-01 00:00 ET
Veeva Systems reported for 2023 q2
SEC form 8
2023-08-30 00:00 ET
Veeva Systems published news for 2023 q2
SEC form 6
2023-08-21 21:34 ET
Veeva Systems published news for 2023 q2
SEC form 6
2023-08-21 16:55 ET
Veeva Systems published news for 2023 q2
SEC form 6
2023-07-03 16:41 ET
Veeva Systems published news for 2023 q2
SEC form 6
2023-07-03 16:38 ET
Veeva Systems published news for 2023 q2
SEC form 10
2023-06-02 00:00 ET
Veeva Systems published news for 2023 q1
SEC form 6
2023-05-31 16:05 ET
Veeva Systems reported for 2023 q1
SEC form 8
2023-05-31 00:00 ET
Veeva Systems published news for 2023 q1
SEC form 6
2023-04-10 20:53 ET
Veeva Systems published news for 2023 q1
SEC form 6
2023-04-10 20:48 ET
Veeva Systems published news for 2023 q1
SEC form 6
2023-04-10 20:46 ET
Veeva Systems published news for 2023 q1
SEC form 6
2023-04-10 20:44 ET
Veeva Systems published news for 2023 q1
SEC form 10
2023-03-30 16:06 ET
Veeva Systems reported for 2022 q4
SEC form 10
2023-03-30 00:00 ET
Veeva Systems reported for 2022 q4
SEC form 6
2023-03-17 16:05 ET
Veeva Systems published news for 2022 q4
SEC form 6
2023-03-07 16:05 ET
Veeva Systems published news for 2022 q4
SEC form 6
2023-03-03 15:37 ET
Veeva Systems published news for 2022 q4
SEC form 6
2023-03-03 15:35 ET
Veeva Systems published news for 2022 q4
SEC form 6
2023-03-03 15:33 ET
Veeva Systems published news for 2022 q4
SEC form 6
2023-03-03 15:30 ET
Veeva Systems published news for 2022 q4
SEC form 6
2023-03-03 15:28 ET
Veeva Systems published news for 2022 q4
SEC form 6
2023-03-03 15:25 ET
Veeva Systems published news for 2022 q4
SEC form 6
2023-03-03 15:22 ET
Veeva Systems published news for 2022 q4
SEC form 6
2023-03-03 15:20 ET
Veeva Systems published news for 2022 q4
SEC form 6
2023-03-03 15:17 ET
Veeva Systems published news for 2022 q4
SEC form 6
2023-03-03 15:13 ET
Veeva Systems published news for 2022 q4
SEC form 6
2023-03-01 16:05 ET
Veeva Systems published news for 2022 q4
SEC form 8
2023-03-01 00:00 ET
Veeva Systems reported for 2022 q4
SEC form 6
2023-01-26 16:05 ET
Veeva Systems published news for 2022 q4
SEC form 10
2022-12-07 16:08 ET
Veeva Systems reported for 2022 q3
SEC form 10
2022-12-07 00:00 ET
Veeva Systems reported for 2022 q3
SEC form 6
2022-12-01 16:05 ET
Veeva Systems published news for 2022 q3
SEC form 8
2022-12-01 00:00 ET
Veeva Systems reported for 2022 q3
SEC form 8
2022-11-08 00:00 ET
Veeva Systems published news for 2022 q3
SEC form 6
2022-11-07 19:54 ET
Veeva Systems published news for 2022 q3
SEC form 6
2022-09-26 16:05 ET
Veeva Systems published news for 2022 q2
SEC form 10
2022-09-02 16:06 ET
Veeva Systems reported for 2022 q2
SEC form 10
2022-09-02 00:00 ET
Veeva Systems reported for 2022 q2
SEC form 6
2022-08-31 16:05 ET
Veeva Systems published news for 2022 q2
SEC form 8
2022-08-31 00:00 ET
Veeva Systems reported for 2022 q2
SEC form 6
2022-08-08 16:32 ET
Veeva Systems published news for 2022 q2
SEC form 6
2022-06-13 16:21 ET
Veeva Systems published news for 2022 q1
SEC form 10
2022-06-03 16:07 ET
Veeva Systems reported for 2022 q1
SEC form 10
2022-06-03 00:00 ET
Veeva Systems reported for 2022 q1
SEC form 6
2022-06-01 16:05 ET
Veeva Systems published news for 2022 q1
SEC form 8
2022-06-01 00:00 ET
Veeva Systems reported for 2022 q1
SEC form 6
2022-04-27 17:18 ET
Veeva Systems published news for 2022 q1
SEC form 10
2022-03-30 17:08 ET
Veeva Systems published news for 2021 q4
SEC form 10
2022-03-30 00:00 ET
Veeva Systems published news for 2021 q4
SEC form 6
2022-03-02 16:05 ET
Veeva Systems published news for 2021 q4
SEC form 8
2022-03-02 00:00 ET
Veeva Systems published news for 2021 q4
SEC form 6
2022-01-25 18:13 ET
Veeva Systems published news for 2021 q4
SEC form 6
2022-01-25 18:12 ET
Veeva Systems published news for 2021 q4
SEC form 6
2022-01-25 18:11 ET
Veeva Systems published news for 2021 q4
SEC form 6
2022-01-25 18:09 ET
Veeva Systems published news for 2021 q4
SEC form 6
2022-01-25 07:02 ET
Veeva Systems published news for 2021 q4
SEC form 10
2021-12-03 16:07 ET
Veeva Systems published news for 2021 q3
SEC form 10
2021-12-03 00:00 ET
Veeva Systems published news for 2021 q3
SEC form 6
2021-12-01 16:05 ET
Veeva Systems published news for 2021 q3
SEC form 8
2021-12-01 00:00 ET
Veeva Systems published news for 2021 q3
SEC form 10
2021-09-03 16:06 ET
Veeva Systems published news for 2021 q2
SEC form 10
2021-09-03 00:00 ET
Veeva Systems published news for 2021 q2
SEC form 6
2021-09-01 16:06 ET
Veeva Systems published news for 2021 q2
SEC form 8
2021-09-01 00:00 ET
Veeva Systems published news for 2021 q2
SEC form 6
2021-06-28 16:11 ET
Veeva Systems published news for 2021 q1
SEC form 10
2021-06-04 17:29 ET
Veeva Systems published news for 2021 q1
SEC form 10
2021-06-04 00:00 ET
Veeva Systems published news for 2021 q1
SEC form 6
2021-05-27 16:04 ET
Veeva Systems published news for 2021 q1
SEC form 8
2021-05-27 00:00 ET
Veeva Systems published news for 2021 q1
SEC form 6
2021-05-10 16:15 ET
Veeva Systems published news for 2021 q1
SEC form 6
2021-04-27 19:12 ET
Veeva Systems published news for 2021 q1
SEC form 6
2021-04-05 19:55 ET
Veeva Systems published news for 2021 q1
SEC form 6
2021-04-05 19:53 ET
Veeva Systems published news for 2021 q1
SEC form 6
2021-04-05 19:51 ET
Veeva Systems published news for 2021 q1
SEC form 6
2021-04-05 19:45 ET
Veeva Systems published news for 2021 q1
SEC form 10
2021-03-30 16:53 ET
Veeva Systems published news for 2020 q4
SEC form 6
2021-03-26 17:01 ET
Veeva Systems published news for 2020 q4
SEC form 6
2021-03-26 16:59 ET
Veeva Systems published news for 2020 q4
SEC form 6
2021-03-26 16:56 ET
Veeva Systems published news for 2020 q4
SEC form 6
2021-03-26 16:54 ET
Veeva Systems published news for 2020 q4
SEC form 6
2021-03-26 16:52 ET
Veeva Systems published news for 2020 q4
SEC form 6
2021-03-26 16:49 ET
Veeva Systems published news for 2020 q4
SEC form 6
2021-03-26 16:46 ET
Veeva Systems published news for 2020 q4
SEC form 6
2021-03-22 16:05 ET
Veeva Systems published news for 2020 q4
SEC form 6
2021-03-16 17:23 ET
Veeva Systems published news for 2020 q4
SEC form 6
2021-03-12 16:25 ET
Veeva Systems published news for 2020 q4
SEC form 6
2021-03-03 16:47 ET
Veeva Systems published news for 2020 q4
SEC form 6
2021-03-02 16:07 ET
Veeva Systems published news for 2020 q4
SEC form 6
2021-02-04 18:09 ET
Veeva Systems published news for 2020 q4
SEC form 6
2021-02-01 17:30 ET
Veeva Systems published news for 2020 q4
SEC form 6
2021-01-14 17:14 ET
Veeva Systems published news for 2020 q4
SEC form 10
2020-12-09 16:30 ET
Veeva Systems published news for 2020 q3
SEC form 6
2020-12-03 16:46 ET
Veeva Systems published news for 2020 q3
SEC form 6
2020-12-01 16:05 ET
Veeva Systems published news for 2020 q3
SEC form 6
2020-10-16 16:31 ET
Veeva Systems published news for 2020 q3